IMMUNOGENE ZUSAMMENSETZUNGEN ENTHALTEND PHOSPHOLIPID

Patent europeic · EP2263687 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2263687
Numer da la dumonda
EP10175899
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
29-12-2003
Publitgà
22-12-2010
Concedì
25-03-2015
Stritgà
31-12-2015
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 47/26 (2006.01)
A61K 9/10 (2006.01)
A61K 9/19 (2006.01)
A61K 9/50 (2006.01)
A61K 39/095 (2006.01)
A61K 39/21 (2006.01)
A61K 39/39 (2006.01)
A61K 47/06 (2006.01)
A61K 9/00 (2006.01)
A61K 9/107 (2006.01)
A61K 9/16 (2006.01)
A61K 39/00 (2006.01)
Prioritad
US 436919 P 27.12.2002
US 513075 P 21.10.2003
Derivà da
EP03800259
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-07-2016

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.07.2016

  2. 25-03-2015

    Concedì

    Published in Swissreg on 25.03.2015

Partidas

Possessur

Novartis Vaccines and Diagnostics, Inc.

IP Services, Bldg. 433 257 One Health Plaza, East Hanover, NJ 07936-1080, US

Inventur

O'Hagan, Derek

Berkeley, CA 94705, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.